Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BET1 antisense RNA 1 (BET1-AS1)
- Target
- BET1-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Natural antisense transcript (NAT)
01
Overview
BET1 antisense RNA 1 (BET1-AS1) is a long noncoding RNA classified as a natural antisense transcript. Antisense RNAs, including lncRNAs and NATs, commonly regulate the expression of overlapping or neighboring genes, potentially influencing processes like transcription, RNA splicing, transcript stability, and epigenetic modification, often acting in cis or trans to sense transcripts[2][4]. While many antisense RNAs have crucial regulatory functions and are implicated in disease biology, there is currently no robust, direct evidence that BET1-AS1 itself acts as a therapeutic target or plays a well-defined disease-related role.
- Other names
- BET1-AS1BET1 antisense RNA 1
02
Biological functions
Regulation of gene expressionEpigenetic regulationPotential involvement in RNA processing and transcript stability
03
Disease associations
Other (There is no strong evidence linking BET1-AS1 to specific disease roles, but other NATs/lncRNAs are involved in cancer, neurological, and imprinting disorders)
Beyond the preview
Go deeper on BET1 antisense RNA 1 (BET1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BET1 antisense RNA 1 (BET1-AS1).